Digital Commodities shifts to two-tier digital-asset treasury, targets AI-driven blockchain infrastructure exposure
Bitget2026/10/06 12:47Digital Commodities Capital set a two-tier treasury strategy focused on Bitcoin reserves, cash, and a separate AI-driven digital-asset allocation. Reserve foundation to remain anchored by 11 Bitcoin, with further reductions to Bitcoin requiring separate board approval and disclosure. Growth allocation to be built in measured stages, targeting assets where network activity can plausibly translate into token demand or value accrual. Management plans to keep evaluating additional established or emerging digital assets using adoption, utility, activity, and token-economics criteria. Portfolio sizing and composition to be reviewed periodically as the strategy develops and market conditions evolve. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Digital Commodities Capital Corp. published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.
- Digital Commodities Capital set a two-tier treasury strategy focused on Bitcoin reserves, cash, and a separate AI-driven digital-asset allocation.
- Reserve foundation to remain anchored by 11 Bitcoin, with further reductions to Bitcoin requiring separate board approval and disclosure.
- Growth allocation to be built in measured stages, targeting assets where network activity can plausibly translate into token demand or value accrual.
- Management plans to keep evaluating additional established or emerging digital assets using adoption, utility, activity, and token-economics criteria.
- Portfolio sizing and composition to be reviewed periodically as the strategy develops and market conditions evolve.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.
JPMorgan raises AbbVie target price to $300